Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers in Nonalcoholic Fatty Liver Disease
Manuela G. Neuman, Lawrence B. Cohen, Radu M. Nanau
Canadian Journal of Gastroenterology and Hepatology (2014) Vol. 28, Iss. 11, pp. 607-618
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Metabolism disrupting chemicals and metabolic disorders
Jerrold J. Heindel, Bruce Blumberg, Mathew C. Cave, et al.
Reproductive Toxicology (2016) Vol. 68, pp. 3-33
Open Access | Times Cited: 916
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
Vincent Wai‐Sun Wong, Wah‐Kheong Chan, Shiv Chitturi, et al.
Journal of Gastroenterology and Hepatology (2017) Vol. 33, Iss. 1, pp. 70-85
Open Access | Times Cited: 451
Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
Lili Niu, Philipp E. Geyer, Nicolai J. Wewer Albrechtsen, et al.
Molecular Systems Biology (2019) Vol. 15, Iss. 3
Open Access | Times Cited: 229
Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
Rosa Divella, Antonio Mazzocca, Antonella Daniele, et al.
International Journal of Biological Sciences (2019) Vol. 15, Iss. 3, pp. 610-616
Open Access | Times Cited: 143
As We Drink and Breathe: Adverse Health Effects of Microcystins and Other Harmful Algal Bloom Toxins in the Liver, Gut, Lungs and Beyond
Apurva Lad, Joshua D. Breidenbach, Robin C. Su, et al.
Life (2022) Vol. 12, Iss. 3, pp. 418-418
Open Access | Times Cited: 78
Smart Contact Lenses as Wearable Ophthalmic Devices for Disease Monitoring and Health Management
Hunkyu Seo, Won Gi Chung, Yong Won Kwon, et al.
Chemical Reviews (2023) Vol. 123, Iss. 19, pp. 11488-11558
Open Access | Times Cited: 53
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 27
The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
Hongsheng Li, Yanli Hou, Xin Wang, et al.
Pharmacological Research (2025) Vol. 213, pp. 107647-107647
Open Access | Times Cited: 1
Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
Xiaolin Huang, Min Xu, Ying Chen, et al.
Medicine (2015) Vol. 94, Iss. 40, pp. e1682-e1682
Open Access | Times Cited: 166
Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood
Martin Decaris, Kelvin W. Li, Claire Emson, et al.
Hepatology (2016) Vol. 65, Iss. 1, pp. 78-88
Open Access | Times Cited: 91
Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?
Jun Liong Chin, Michael Pavlides, Ahmad Moolla, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 89
Pediatric NAFLD: an overview and recent developments in diagnostics and treatment
Laura G. Draijer, Marc A. Benninga, Bart G.P. Koot
Expert Review of Gastroenterology & Hepatology (2019) Vol. 13, Iss. 5, pp. 447-461
Closed Access | Times Cited: 84
Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression
Tereza C. M. Fontes-Cal, Rafael T. Mattos, Nayara I. Medeiros, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
Richeek Pradhan, Hui Yin, Oriana Hoi Yun Yu, et al.
Diabetes Care (2022) Vol. 45, Iss. 4, pp. 819-829
Open Access | Times Cited: 38
Bioactive Compounds, Health Benefits and Food Applications of Artichoke (Cynara scolymus L.) and Artichoke By-Products: A Review
Pablo Ayuso, Jhazmin Quizhpe, María de los Ángeles Rosell, et al.
Applied Sciences (2024) Vol. 14, Iss. 11, pp. 4940-4940
Open Access | Times Cited: 7
Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach
Hong Chang, Hongyu Meng, Shumin Liu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 77
Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress
Caifeng Xie, Zhen Chen, Chengfu Zhang, et al.
Life Sciences (2016) Vol. 157, pp. 131-139
Closed Access | Times Cited: 73
Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
Lucia Kořínková, Veronika Pražienková, Lucie Černá, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 66
Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1/AMPK/NRF2 Signaling
Yunyi Zou, Zhanglin Chen, Chen‐Chen Sun, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 10940-10940
Open Access | Times Cited: 47
Screening for MAFLD: who, when and how?
Shreya C. Pal, Nahúm Méndez‐Sánchez
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14, pp. 204201882211456-204201882211456
Open Access | Times Cited: 15
Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms
Tanmoy Banerjee, Arnab Sarkar, Sk Zeeshan Ali, et al.
Planta Medica (2024) Vol. 90, Iss. 09, pp. 675-707
Open Access | Times Cited: 5
Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices
Pervej Alom Barbhuiya, Ameena Ahmed, Partha Dutta, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Closed Access
From peel to health: jaboticaba’s phenolics counteract oxidative stress and liver fat buildup
Kéllen Wanessa Coutinho Viana, Larissa Lorrane Rodrigues Borges, Amanda Laís Alves Almeida Nascimento, et al.
Food, Nutrition and Health. (2025) Vol. 2, Iss. 1
Open Access
Sodium-Glucose Transport Protein-2 Inhibitors in the Treatment of Non-alcoholic Steatohepatitis: An Evidence-Based Review
Xueyan Lv, Dianchao Mi Mi, Yan Xin, et al.
Hepatitis Monthly (2025) Vol. 25, Iss. 1
Open Access
In vitro liver models for toxicological research
Ichiro Fukunaga, Takanori Takebe
Drug Metabolism and Pharmacokinetics (2025), pp. 101478-101478
Closed Access
Page 1 - Next Page

Scroll to top